Understanding survival comparisons in nonrandomized treatment comparisons for patients with early-stage HCC

Affiliations

Comment

Divya Khosla et al. Hepatol Commun. 2023.

. 2023 Dec 15;8(1):e0281.

doi: 10.1097/HC9.0000000000000281. eCollection 2024 Jan 1.

No abstract available

Conflict of interest statement

The authors have no conflicts to report.

Thermal ablation compared to stereotactic body radiation therapy for hepatocellular carcinoma: A multicenter retrospective comparative study.
Moon AM, Kim HP, Singal AG, Owen D, Mendiratta-Lala M, Parikh ND, Rose SC, McGinty KA, Agala CB, Burke LM, Abate A, Altun E, Beyer C, Do J, Folkert MR, Forbes C, Hattangadi-Gluth JA, Hayashi PH, Jones K, Khatri G, Kono Y, Lawrence TS, Maurino C, Mauro DM, Mayo CS, Pak T, Patil P, Sanders EC, Simpson DR, Tepper JE, Thapa D, Yanagihara TK, Wang K, Gerber DA. Moon AM, et al. Hepatol Commun. 2023 Jun 14;7(7):e00184. doi: 10.1097/HC9.0000000000000184. eCollection 2023 Jul 1. Hepatol Commun. 2023. PMID: 37314737 Free PMC article.

1. Moon AM, Kim HP, Singal AG, Owen D, Mendiratta-Lala M, Parikh ND, et al. . Thermal ablation compared to stereotactic body radiation therapy for hepatocellular carcinoma: A multicenter retrospective comparative study. Hepatol Commun. 2023;7:e00184. - PMC - PubMed
1. Rim CH, Lee JS, Kim SY, Seong J. Comparison of radiofrequency ablation and ablative external radiotherapy for the treatment of intrahepatic malignancies: A hybrid meta-analysis. JHEP Rep. 2022;5:100594. - PMC - PubMed
1. Kim N, Cheng J, Jung I, Liang J, Shih YL, Huang WY, et al. . Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma. J Hepatol. 2020;73:121–129. - PubMed